17.34000 USD
0.64
3.56%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
17.22000
18.17000
Previous close
17.98000
Open
18.13500
Access this stock data via API
Subscribe
Denali Therapeutics Inc.
17.34
0.64
3.56%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 102.0M 102.7M 116.2M 99.8M
Selling general and admin 35.5M 32.3M 29.4M 30.1M
Other operating expenses
Operating income -137.4M -135.0M -145.6M -129.8M
Non operating interest income
Income 10.5M 10.8M 12.6M 15.2M
Expense
Other income expense 0
Pretax income -126.9M -124.1M -133.0M -114.7M
Tax provision
Net income -126.9M -124.1M -133.0M -114.8M
Basic EPS -0.7 -0.7 -0.8 -0.7
Diluted EPS -0.7 -0.7 -0.8 -0.7
Basic average shares 172.4M 171.4M 171.2M 170.1M
Diluted average shares 172.4M 171.4M 171.2M 170.1M
EBITDA -133.6M -131.0M -142.4M -127.2M
Net income from continuing op. -126.9M -124.1M -133.0M -114.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 3 hours 31 minutes

00:28
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).